A Phase II, Randomized, Parallel-Group, Double-Blind,
Placebo-Controlled, Multicenter Study To Evaluate The Efficacy,
Safety, and Pharmacokinetics of BFKB8488A Compared With
Placebo In Patient With Non-Alcoholic Steatohepatitis
Please contact us for more information or to learn if you are eligible to participate.
